Patient-reported outcomes of neurologic and neuropsychiatric symptoms in mild COVID-19: a prospective cohort study

A Ganesh, RE Rosentreter, Y Chen, R Mehta… - … Open Access Journal, 2023 - cmajopen.ca
Background: Various neurologic manifestations have been reported in patients with COVID-
19, mostly in retrospective studies of patients admitted to hospital, but there are few data on …

Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis (N6. 001)

L Premraj, N Kannapadi, J Briggs, D Battaglini… - 2022 - AAN Enterprises
Objective: To determine the prevalence of neurological and neuropsychiatric symptoms
reported 12 weeks (3 months) or more after acute COVID-19 onset in adults. Background …

Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort study

V Rass, R Beer, AJ Schiefecker… - European journal of …, 2022 - Wiley Online Library
Background and purpose Neurological sequelae from coronavirus disease 2019 (COVID‐
19) may persist after recovery from acute infection. Here, the aim was to describe the natural …

Neurological symptoms, comorbidities, and complications of COVID-19: a literature review and meta-analysis of observational studies

K Vakili, M Fathi, M Hajiesmaeili, M Salari… - European …, 2021 - karger.com
Background: Recently, it has been shown that coronavirus disease 2019 (COVID-19), which
has caused a pandemic since December 2019, can be accompanied by some neurological …

Three-month outcomes in hospitalized COVID-19 patients

JPJ Savarraj, AB Burkett, SN Hinds, AS Paz, A Assing… - MedRxiv, 2020 - medrxiv.org
COVID-19 is an ongoing pandemic with a devastating impact on public health. Acute
neurological symptoms have been reported after a COVID-19 diagnosis, however there is …

Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis

L Premraj, NV Kannapadi, J Briggs, SM Seal… - Journal of the …, 2022 - Elsevier
Importance Neurological and neuropsychiatric symptoms that persist or develop three
months after the onset of COVID-19 pose a significant threat to the global healthcare system …

Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort study

V Rass, R Beer, AJ Schiefecker, M Kofler… - European journal of …, 2021 - Wiley Online Library
Background and purpose To assess neurological manifestations and health‐related quality
of life (QoL) 3 months after COVID‐19. Methods In this prospective, multicenter …

Neuropsychiatric and cognitive outcomes in patients 6 months after COVID-19 requiring hospitalization compared with matched control patients hospitalized for non …

V Nersesjan, L Fonsmark, RHB Christensen… - JAMA …, 2022 - jamanetwork.com
Importance Prolonged neuropsychiatric and cognitive symptoms are increasingly reported in
patients after COVID-19, but studies with well-matched controls are lacking. Objective To …

[HTML][HTML] Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients

J Hellmuth, TA Barnett, BM Asken, JD Kelly… - Journal of …, 2021 - Springer
As cases of coronavirus disease 2019 (COVID-19) mount worldwide, attention is needed on
potential long-term neurologic impacts for the majority of patients who experience mild to …

[HTML][HTML] A neurological outpatient clinic for patients with post-COVID-19 syndrome—a report on the clinical presentations of the first 100 patients

F Boesl, H Audebert, M Endres, H Prüss… - Frontiers in …, 2021 - frontiersin.org
Background and Objectives: Neurological and psychiatric symptoms are frequent in patients
with post-COVID-19 syndrome (PCS). Here, we report on the clinical presentation of the first …